This funding opportunity supports SBIR/STTR applications focused on RNA delivery technologies enabling specific tissue targeting to enhance treatment of heart, lung, blood, and sleep diseases. Projects may include non-viral gene editing delivery, targeted RNA therapeutics, novel lung delivery methods, and AI/ML approaches for optimizing targeted nanoparticles and preclinical development.
Eligibility details are not specified in the notice.
